Related Experiment Video
Updated: May 17, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
[Hepatitis B: screening and treatment]
1Département d'Hépato-Gastroentérologie, C.H.U. Saint-Pierre, Bruxelles. jean-pierre_mulkay@stpierre-bru.be
Insights
Hepatitis B virus (HBV) infection is common and often asymptomatic, leading to underdiagnosis. Early screening, vaccination, and new antiviral treatments can prevent severe liver disease progression.
Area of Science:
- Hepatology
- Virology
- Public Health
Context:
- Hepatitis B virus (HBV) infection is a significant global health concern, surpassing HIV and HCV in prevalence.
- Chronic hepatitis B (CHB) can lead to severe liver complications, including cirrhosis and hepatocellular carcinoma.
- A large proportion of infected individuals remain unaware of their status due to asymptomatic presentation and insufficient screening.
Purpose:
- To review current strategies for the prevention, diagnosis, and treatment of hepatitis B virus infection.
- To highlight the importance of early detection and intervention in managing chronic hepatitis B.
- To discuss the evolving landscape of antiviral therapies for CHB.
Summary:
- HBV infection is highly prevalent, often asymptomatic, and preventable through vaccination.
- Underdiagnosis is a major issue, necessitating improved screening protocols.
- Recent advancements offer effective and tolerable antiviral treatments for CHB, improving patient outcomes.
Impact:
- Emphasizes the critical need for enhanced HBV screening and vaccination programs.
- Underscores the availability of effective treatments to halt liver disease progression.
- Aims to improve patient management and reduce the burden of HBV-related liver disease.
Abstract:
Hepatitis B virus infection is more prevalent than human immunodeficiency virus (HIV) infection and hepatitis C virus infection. Chronic hepatitis B (CHB) is a serious disease that can lead to severe complications as cirrhosis and hepatocellular carcinoma. The vast majority of people with chronic HBV infection are asymptomatic and as many as 2 in 3 people do not know they are infected. This is an indication of under screening by healthcare professionals. However, early treatment and intervention can prevent progression of liver disease. HBV infection is a vaccine-preventable disease. Until recently, there were few treatment options for patients with CHB, but now there are a number of antiviral agents available that are both effective against hepatitis B virus (HBV) and tolerable for the patient. This review paper attempts to provide some answers regarding the prevention, diagnosis and treatment of hepatitis B.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...